Development of nanostructured lipid carriers for intraoral delivery of Domperidone

被引:40
|
作者
Tetyczka, Carolin [1 ]
Griesbacher, Martin [1 ]
Absenger-Novak, Markus [2 ]
Froehlich, Eleonore [2 ]
Roblegg, Eva [1 ,3 ]
机构
[1] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Technol & Biopharm, Graz, Austria
[2] Med Univ Graz, Ctr Med Res, Graz, Austria
[3] Res Ctr Pharmaceut Engn, Graz, Austria
关键词
Nanostructured lipid carriers NLC; Domperidone; Buccal mucosa; Ex-vivo study; In-vitro TR 146 cells; IN-VITRO PERMEABILITY; DRUG-DELIVERY; NANOPARTICLES SLN; PHYSICAL STABILITY; NLC; MUCOSA; TRANSPORT; SKIN;
D O I
10.1016/j.ijpharm.2017.04.076
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The oral cavity displays one potentially attractive route that is not associated with gastric transit and hepatic first pass metabolism. However, poorly soluble active candidates require a drug delivery system to facilitate their transport through oral biological membranes. To this end, nanostructured lipid carriers (NLC) were loaded with Domperidone and produced with high pressure homogenization. NLC were characterized regarding particle size, particle size distribution, zeta potential, entrapment efficiency and crystallinity. Moreover, permeability studies through the buccal mucosa were performed using in-vitro and ex-vivo models. Palmitic acid (solid lipid) and oleic acid (liquid lipid) in the ratio 9:1 were able to dissolve the highest amount of Domperidone. Particle diameters of about 280 nm and monomodal size distribution were obtained. A zeta potential higher than 30 mV was observed over a period of 28 days indicating good physical stability. NLC dispersed in saliva did not agglomerate and were actively internalized by buccal TR 146 cells without causing adverse side effects. Ex-vivo studies confirmed that Domperidone permeated the entire tissue. This leads to the conclusion that NLC are appropriate carrier systems that facilitate the transport of poorly soluble drugs across buccal and sublingual tissue. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:188 / 198
页数:11
相关论文
共 50 条
  • [11] Development and evaluation of cationic nanostructured lipid carriers for ophthalmic drug delivery of besifloxacin
    Baig, Mirza Salman
    Owida, Hamza
    Njoroge, Wanjiku
    Siddiqui, Aquil-ur-Rahim
    Yang, Ying
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 55
  • [12] Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model
    Li, Jun
    Yang, Min
    Xu, Wenrong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 2241 - 2248
  • [13] Impact of liquid lipid on development and stability of trimyristin nanostructured lipid carriers for oral delivery of resveratrol
    Houacine, Chahinez
    Adams, David
    Singh, Kamalinder K.
    JOURNAL OF MOLECULAR LIQUIDS, 2020, 316
  • [14] Targeted nanostructured lipid carriers for doxorubicin oral delivery
    Moraes, S.
    Marinho, A.
    Lima, S.
    Granja, A.
    Araujo, J. P.
    Reis, S.
    Sousa, C. T.
    Nunes, C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 592
  • [15] Nanostructured Lipid Carriers for the Delivery of Natural Bioactive Compounds
    Shamsuddin, Nur Amira Mohd
    Zulfakar, Mohd. Hanif
    CURRENT DRUG DELIVERY, 2023, 20 (02) : 127 - 143
  • [16] Nanostructured lipid carriers as a favorable delivery system for β-carotene
    Pezeshki, Akram
    Hamishehkar, Hamed
    Ghanbarzadeh, Babak
    Fathollahy, Isa
    Nahr, Fatemeh Keivani
    Heshmati, Maryam Khakbaz
    Mohammadi, Maryam
    FOOD BIOSCIENCE, 2019, 27 : 11 - 17
  • [17] Microencapsulated nanostructured lipid carriers as delivery system for rutin
    Gan, Liang
    Zhang, Chen
    Wu, Fengjuan
    Li, Hong
    Zhang, WanPing
    Zhang, Qianjie
    MATERIALS TECHNOLOGY, 2018, 33 (05) : 357 - 363
  • [18] Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen
    Han, Fei
    Li, Sanming
    Yin, Ran
    Shi, Xiaolei
    Jai, Qiang
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2008, 34 (04) : 453 - 458
  • [19] Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting
    Fang, Chia-Lang
    Al-Suwayeh, Saleh A.
    Fang, Jia-You
    RECENT PATENTS ON NANOTECHNOLOGY, 2013, 7 (01) : 41 - 55
  • [20] Development and evaluation of lipid nanoparticles for paclitaxel delivery: a comparison between solid lipid nanoparticles and nanostructured lipid carriers
    Xu W.
    Lee M.-K.
    Journal of Pharmaceutical Investigation, 2015, 45 (7) : 675 - 680